www.ohioacc.org

Register Now |  Interactive Brochure |  pdf Brochure | Exhibitor info

5th Annual CCA Cardiovascular Update &

49th Annual Carl J. Wiggers Memorial Lecture

April 18, 2012 | The Ritz-Carlton, Cleveland

You can register online.

Meeting Location

The Ritz-CarltonCleveland

1515 West Third Street

Cleveland,Ohio44113

(216) 623-1300

Cancellations

Cancellation requests must be received by Wednesday, April 11, 2012. No refunds will be made after that date.

Statement of Need

Cardiovascular disease is the leading health care problem throughout the world.  In theUnited Statesalone, an estimated 70 million people have been diagnosed with one or more forms of cardiovascular disease (CV), and over 910,000 Americans die from CV disease each year. The cardiac care team is increasingly asked to develop systems of care, the methods for which are not necessarily part of the traditional medical training. We are asked to do this better, faster, more efficiently and at a lower cost.

Overall Goal

Physicians and cardiac care associates are required to maintain up-to-date knowledge of the latest clinical developments in the practice of cardiology to improve patient outcomes. The overall goal of this activity is to increase learner competence by discovering strategies to anticipate research-driven changes in practice, to enhance professional growth, and to demonstrate efficacy in team based patient care practice as new clinical approaches and technologies change. Physicians and cardiac care associates are required to maintain up-to-date knowledge of the latest clinical developments in the practice of cardiology to improve patient outcomes. The Ohio Chapter-ACC Spring Summit will include education that provides needs-based learning covering a thorough overview of inherited cardiomyopathies, cardiovascular pharmacology, resistant hypertension,  lipid management, and substrate mapping in CAD.

Learner Objectives

Upon completion of this program, participants should be able to:

• Analyze how Personalized Medicine will change the way cardiovascular practitioners will practice medicine in the future.
• Review recent literature and research studies in comparison to existing ACC/AHA guidelines in pharmacological management of the cardiovascular patient.
• Address common problems unique to adult patients with resistant hypertension that will be seen in the cardiovascular practice.
• Identify clinical guidelines and discuss recent research to review lipid treatment goals.
• Describe the anatomic substrate for VT/VF, eletrophysiologic markers of this substrate, and how the substrate can be modified by ablation to prevent VT/VF.

Target Audience

Adult Cardiologists, Pediatric Cardiologists, Cardiothoracic Surgeons, Cardiology Fellows-in-Training, Internal Medicine Physicians, Private Practice Physicians, Nurses, Nurse Practitioners, Clinical Nurse Specialists, Physician Assistants, Pharmacists

ACCF Disclosure & COI Policy Statement

ACCF/Chapter committee members, faculty, staff and other individuals who are in a position to control the content of this activity are required to disclose all real or apparent conflicts of interest. All relevant potential conflicts of interest that are identified are thoroughly vetted through a process that includes course directors and appropriate peer review by education committee chairs/members, for fair balance, scientific objectivity and validity, patient care and safety recommendations. Full disclosure will be published in the syllabus.